MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

MDT

87.13

-1.01%↓

A

119.41

-0.9%↓

VEEV

167.53

+5.63%↑

HQY

83.87

+3.38%↑

NEOG

9.43

-1.77%↓

Search

Atossa Therapeutics Inc

Open

5.67 7.39

Overview

Share price change

24h

Current

Min

5.31

Max

5.6899999999999995

Key metrics

By Trading Economics

Income

-2.2M

-11M

Employees

16

EBITDA

-2.7M

-11M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+245.2% upside

Market Stats

By TradingEconomics

Market Cap

-4M

44M

Previous open

-1.72

Previous close

5.67

Technical Score

By Trading Central

Confidence

Bullish Evidence

Atossa Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 Jan 2026, 23:29 UTC

Hot Stocks

Stocks to Watch: Atossa Therapeutics, Union Pacific

Peer Comparison

Price change

Atossa Therapeutics Inc Forecast

Price Target

By TipRanks

245.2% upside

12 Months Forecast

Average 18.33 USD  245.2%

High 25 USD

Low 10 USD

Based on 3 Wall Street analysts offering 12 month price targets forAtossa Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

0.7955 / 0.898Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bullish Evidence

Long Term

Weak Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat